User:Braiteh/sandbox

Fadi S. Braiteh is a medical oncologist, clinical researcher and partner at Comprehensive Cancer Centers of Nevada (CCCN). He serves as a principal investigator for numerous clinical research trials though UCLA-TRIO-US and US Oncology Research network  since 2010, mostly in gastrointestinal, thoracic malignancies and Phase I drug development. Additionally, Dr. Braiteh directs the Translational Oncology Program (TOP-Phase I) at CCCN for the development of novel anti-cancer agents. He collaborates with the Nevada Cancer Research Foundation, one of the handulf first Community Clinical Oncology Programs in USA established in 1983. Braiteh is in certified physician investigator through ACRP ,and a Diplomat of the American Board of Internal Medicine, Palliative and Hospice Medicine and Medical Oncology with expertise in gastro-intestinal and thoracic oncology. Prior to CCCN, Dr. Braiteh was the director of Phase I program and developmental therapeutics at the Cancer and Hematology Centers of Western Michigan. During this time, he was a clinical assistant professor of medicine at the School of Human Medicine at Michigan State University, and scientific investigator for Program of Translational Medicine and Phase 1 clinical trials at Van Andel Research Institute in Grand Rapids, Michigan.

Dr. Braiteh is a member of the lecturing faculty with numerous professional societies including American Society of Clinical Oncology, American Medical Association, Academy of Clinical Research Professionals, and Academy of Pharmaceutical Physicians and Investigators. He has authored and co-authored more than 50 original peer-reviewed manuscripts, abstracts and book chapters. Dr. Braiteh has been featured in The New York Times in relation to his work with gene mutations and he has been repeatedly named among America’s top medical oncologists by Castle-Connolly, US News & World Report and Las Vegas Life. He has also received numerous honors including “Medical Marvel” from Nevada Business magazine, the Patients Top Choice Award, Top Researcher Award, Susan G. Komen for the Cure Award, the M.D. Anderson Cancer Center Employee Achievement Award and the ASCO Foundation Merit Award among others.

Dr. Braiteh received his medical degree from Saint Joseph University Faculty of Medicine in Beirut, Lebanon in 1998. He was the Recipient of the Ge is pursue further training and received a Diplôme Universitaire (D.U.) in Forensic Medicine in the year 2000 from Saint Joseph University Faculty of Medicine as well. He trained for 2 years in Otorhinolaryngology at Hotel-Dieu de France, Saint Joseph University Faculty of Medicine teaching hospital, before moving to the USA for post-graduate training. He receiced training in Internal Medicine at the Hospital of Saint Raphael, Yale School of Medicine in New Haven Connecticut between July 2000 and graduated June 2003. He then completed three fellowships at the University of Texas M. D. Anderson Cancer Center (UTMDACC) in Houston, Texas: Palliative care and Hospice Mdicine between 2003 and 2004, under the tutorship of Eduardo Bruera,MD. Thereafter completed a 2-year Phase I drug development fellowship under the mentorship of Razelle Kurzrock,MD in 2006. He pursued further training in Medical Oncology at UTMDACC with focus on Gastro-intestinal and Thoracic malignancies in 2009. During his fellowships at UTMDACC, he was awarded additional extra-mural training special programs: Personal Development and Workshop Training 1.The Molecular and Translational Oncology Workshop, the Cancer Education Consortium, Amelia Island, Florida, April 2007. 2.The AACR Workshop on Molecular Biology in Clinical Oncology, Aspen, Colorado, July 2006. 3.The Duke/AACR/ASCO Accelerating Anticancer Agent Development and Validation Workshop, North Bethesda, Maryland, May 2006. 4.The ASCO/AACR Workshop on Methods in Clinical Cancer Research, Vail, Colorado, July 2005. 5.The Roles of Physicians and scientists in the Business World (HST 906):, June 10, 2005. (Olie Wenker, MD MBA and Stephen Tomasivic,PhD, University of Texas M. D. Anderson Cancer Center, Harvard School of Medicine and Massachusetts Institute of Technology. 6.Cancer biology curriculum, Human Biology and Patient-based Biological research, the Graduate School of Biomedical Sciences, The University of Texas Health Sciences Center in Houston. 09/2005- 07/2008.

Over the years he served on numerous National and State Committees: 1.Member, Data Safety Monitoring NAPOLI 1 trial in pancreatic cancer, Merrimack Pharmaceuticals (NCCP), August 2012-current 2.Member, Board of Directors, Nevada Colon Cancer Partnership (NCCP), August 2011-current 3.Member, Thoracic Ooncology Committee, US Oncology, Woodlands, Texas, 06/2011-current. 4.Member, Developmental Therapeutics Committee, US Oncology, Woodlands, Texas, 08/2010-current. 5.Member, Gastro-intestinal Oncology Committee, US Oncology, Woodlands, Texas, 08/2010-current. 6.Member, Translational Oncology Program Committee, US Oncology, Woodlands, Texas, 08/2010-current. 7.Member, Career Development Subcommittee, the Professional Development Committee at the American Society of Clinical Oncology (ASCO) Alexandria, Virginia 2009-2012. 8.Liaison member of the Career Development Subcommittee to the Cancer Communication Committee at the American Society of Clinical Oncology (ASCO) Alexandria, Virginia 2010-2011. 9.Liaison member of the to the ASCO Scientific Program Committee, The American Society of Clinical Oncology (ASCO) Alexandria, Virginia 2009-2010. 10.Liaison member of the Career Development Subcommittee to the Scientific Program Committee at the American Society of Clinical Oncology (ASCO) Alexandria, Virginia 2009-2010. 11.Member, Executive Committee for Cattle Baron’s Ball Fund raising, the American Cancer Society (ACS) Grand Rapids, Michigan 2009-2010. 12.Alternate Delegate of the Connecticut State Medical Society (CSMS) to the Residents and Fellows Section, American Medical Association (AMA) Interim meeting in New Orleans, Louisiana December 2002.

Some of the Honors and Awards Dr Braiteh received: 1.	“2013 America’s Top Oncologists” by Castle-Connolly and US World News Report, 2013. 2.	“Top Doctors 2013” by Las Vegas Life, Spring 2013 3.	The “2012 Patients Top Choice Award” 4.	Top Accrual Award, US Oncology Research, Annual Community Research meeting, Dallas, Texas 09/20/2012. 5.	“2012 Top Medical Oncologists in Las Vegas ” by Castle-Connolly America’s Top Doctors and Desert Companion, 2012. 6.	“Top Doctors 2012” by Las Vegas Life, Spring 2012 7.	“2012 Nevada’s Top Physicians” by Nevada Business Medical Marvels ,May 2012 8.	“2012 America’s Top Oncologist” by the US World News Report, 2012. 9.	“2011 Top Oncologists in Las Vegas” by Castle-Connolly America’s Top Doctors, 2011. 10.	The Susan G. Komen for the Cure® Scholar-in-Training Award for the 2009 AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, Carefree, Arizona, February 2009. 11.	“2009 America’s Top Oncologists” listing by in the Consumers’ Research Council of America, July 2009. 12.	The 2008 M. D. Anderson Cancer Center Employee Achievement Award, the University of Texas M. D. Anderson Cancer Center, Houston, Texas, September 2008. 13.	“2008 America’s Top Physicians” listing by in the Consumers’ Research Council of America 2008 edition, July 2008. 14.	The 2007 Texas Society Medical Oncology Excellence Award, the Texas Society of Medical oncology annual meeting in Houston, Texas, 13 October 2007. 15.	The 2007 Jesse Jones Fellowship in Cancer Education Award, the Jesse Jones Foundation, Houston, Texas, May 2007. 16.	The 2007 Molecular and Translational Oncology Workshop scholarship, the Cancer Education Consortium, Amelia Island, Florida, April 2007. 17.	The 2006 AACR Workshop on Molecular Biology in Clinical Oncology scholarship, Aspen, Colorado, July 2006. 18.	The 2006 ASCO Foundation Merit Award, American Society of Clinical Oncology, Atlanta, Georgia, June 2006. 19.	The 2006 Berlex Oncology Platform Award in Patient-Oriented Research, (2nd position) Trainee Recognition Day, The University of Texas M. D. Anderson Cancer Center, May 2006. 20.	The 2006 Duke/AACR/ASCO Accelerating Anticancer Agent Development and Validation Workshop scholarship, North Bethesda, Maryland, May 2006. 21.	The 2005 Health Education Apple Award recipient, The University of Texas M. D. Anderson Cancer Center, October 2005. 22.	The 2005 ASCO/AACR Workshop on Methods in Clinical Cancer Research scholarship, Vail, Colorado, July 2005. 23.	The 2005 Berlex Oncology Poster Award in Patient-Oriented Research, Trainee Recognition Day, The University of Texas M. D. Anderson Cancer Center, May 2005. 24.	The 2005 ASCO Foundation Merit Award, American Society of Clinical Oncology, Orlando, Florida, May 2005. 25.	The Monbusho Scholarship (Japanese Education Ministry) for research and training in Internal Ear Diseases at Nagoya University Hospitals, Marsh 2000. 26.	The 1998 Dean’s Medical Studies Award, 1st place prize for the best End-of-Studies thesis, Saint Joseph University, Beirut, Lebanon 1998. 27.	The Michelle Serres Bioethics Award, Saint Joseph University, Beirut, Lebanon1998. 28.	The Hariri Foundation College Scholarship (full tuition merit scholarship for Medical School), 1991-1998. 29.	The Distinguished French Composition Award, Mont-La-Salle High School, 1988

A selection of peer-revewed manuscipts Dr Braiteh published includes the following: 1. Braiteh F. Reply to Beatty et al. J Clin Oncol 2013 July 7; 31 (7): 2752. 2. Roth B., Krilov L., Adams S., Aghajanian C, Bach P, Braiteh F, Brose M, Ellis L, Erba H, George D, Gilbert M, Jacobson J, Eric Larsen, Lichtman S, Partridge A, Patel J, Quinn D, Robison L., Von Roenn J, Samlowski W, Schwartz G, Vogelzang N. Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol 2013, Jan 1; 31(1) 131-61. 3.	Braiteh F. Tsimberidou A., Kurzrock R. Ultimate fate of oncology Dugs approved by the Food and Drug Administration without a randomized trial. J Clin Oncol 2009 Dec 20;27(36):6243-50. 4.	Braiteh F., Correa A., Hofstetter WL, Lee JH, Rice DC, Vaporciyan AA, Bhutani MS, Ross WA, Komaki R., Dekovich A., Swisher SG, Ajani JA. Association of Age and Survival in Patients with Gastroesophageal Cancer Undergoing Surgery With or Without Preoperative Therapy. Cancer 2009 Oct 1;115(19):4450-8. 5.	Braiteh F. and Plana J. Spontaneous haemopericardium with subacute cardiac tamponade in a patient with lung cancer receiving coumadin. Q J Med 2009;102(8):575. 6.	Braiteh F., Kurzrock R. What was ahead of such a Head Injury? Gastroenterology 2009 Jun;136(7):e3-6. 7.	Braiteh F. and Row M. Right ventricular acrylic cement embolism: late complication of percutaneous vertebroplasty Heart 2009 Apr;95(4):275. 8.	Braiteh F. Parikh A., McLaughlin. R. A Case of Chikungunya Fever Leading to the Diagnosis of Angioimmunoblastic T-Cell Lymphoma. Acta Oncol. 2009;48(4):624-8. 9.	Braiteh F., Malik R. Pneumopericardium. Canadian Medical Association Journal 2008 Nov 4; 179(10):1087. 10.	Braiteh F., Soriano A., Garcia-Manero G., Hong D., Johnson M.M., De Padua Silva L., Yang H, Alexander S., Wolff J., Kurzrock R. Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers. Clinical Cancer Research 2008 Oct 1;14(19):6296-6301. 11.	Braiteh F., Hymes S., Giralt S., Jones R., Psoriasis remission after autologous peripheral blood stem cell transplantation for multiple myeloma. J Clin Oncol 2008 Sep 20;26(27):4511-3. 12.	Braiteh F., Kurzrock R. and Johnson F. Trichomegaly of the Eyelashes after Treatment with the Epidermal Growth Factor Receptor Inhibitor Erlotinib for Lung Cancer with EGFR Mutation J Clinical Oncology. 2008 Jul 20;26(20):3460-2. 13.	Fadul N, Elsayem A, Palmer L, Braiteh F., Bruera E. Predictors of Access to Palliative Care Services (APCS) Among Patients Who Died at a Comprehensive Cancer Center. J Palliat Med. 2007 Oct;10(5):1146-52. 14.	Braiteh F, Yao J. What does the rose nose disclose? Gastroenterology 2007 Oct;133(4):e1-e2. 15.	Braiteh F., Elosta B, Palmer L, Reddy S, Bruera E. Patients' characteristics and outcomes of palliative care inpatient consults at a comprehensive cancer center. J Palliat Med. 2007 Aug;10(4):948-55. 16.	Braiteh F., Kurzrock R. Uncommon Tumors But Exceptional Therapies: Paradox or Paradigm? Molecular Cancer Therapeutics 2007 Apr;6(4):1175-1179. 17.	Braiteh F., Row M. Feeling Bloated. Am J Emerg Med. 2007 Feb;25(2):207-8. 18.	Braiteh F., Cohen P, Kurzrock R. CAT scan reveals “Bat sign”. Lancet 2007 Jan 20; 369(9557): 217 19.	Braiteh F., Golden M. Cryptogenic invasive Klebsiella pneumoniae liver abscess. Int J Infect Dis. 2007 Jan;11(1):16-22 20.	Braiteh F. “I’ve got bad news. You have Cancer” J Natl Med Assoc. 2006 Nov;98(11):1882-3. 21.	Braiteh F., Nash I. Pulmonary embolism or Pneumocystis carinii pneumonia: one diagnosis does not exclude the other. Breathe 2006 Sep;3(1):83-88. 22.	Braiteh F., Lim JT, Kurzrock R. Smiley Face. Clinical Anatomy. 2006 Sep 8;19(7):682-683. 23.	Braiteh F., Abrahams J. Hemiparesis following sunbathing. Am J Emerg Med. 2006 May;24(3):380-382. 24.	Braiteh F., Ng C, Kurzrock R. Refractory Hodgkin’s lymphoma responds to pentostatin (2'-deoxycoformycin). Leukemia Lymphoma. 2006 Feb;47(2):373-5. 25.	Braiteh F., Kurzrock R. Langerhans Cell Histiocytosis of the Thyroid. J Clin Oncol 2006 Jan 20;24(3):522-3. 26.	Braiteh F., Boxrud C, Esmaeli B, Kurzrock R. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha Blood. 2005 Nov 1;106(9):2992-4. 27.	Braiteh F., Ramsey W. Transient pneumobilia following upper gastrointestinal endoscopy. American Journal of Gastroenterology 2005 Oct;100(10):2364-5. 28.	Li L, Braiteh F, Kurzrock R. Liposome-Encapsulated Curcumin: In Vitro and In Vivo Effects on Proliferation, Apoptosis, Signaling, and Angiogenesis. Cancer 2005 Sep 15;104 (6):1322-31. 29.	Yennurajalingam S., Braiteh F., Bruera E. Pain and terminal delirium research in the elderly. Clinics in Geriatric Medicine. 2005 Feb;21(1): 93-119